Arcxis Biotechnologies

About:

Arcxis Biotechnologies is focused on developing elegant, integrated and compact solutions to molecular diagnostic challenges.

Website: http://www.arcxis.com

Top Investors: In-Q-Tel, Kaiser Permanente Ventures, Alafi Capital, Claremont Creek Ventures

Description:

Arcxis Biotechnologies is focused on developing elegant, integrated and compact solutions to molecular diagnostic challenges. From proprietary microfluidics to advanced detection methods; streamlined sample preparation to comprehensive automation technology, we are in the business of making molecular methods more reliable, robust and accessible.

Total Funding Amount:

$3.69M

Estimated Revenue Range:

$10M to $50M

Headquarters Location:

Pleasanton, California, United States

Founded Date:

2004-01-01

Contact Email:

information(AT)arcxis.com

Founders:

Brent Satterfield, Jay West, John Jansen, Kyle Hukari

Number of Employees:

1-10

Last Funding Date:

2010-05-25

IPO Status:

Private

Industries:

© 2025 bioDAO.ai